Headquartered in Pleasanton, California, Veeva Systems Inc. (VEEV) is a cloud software company serving the life sciences industry. With a market capitalization of $38.7 billion, the company provides solutions for clinical trials, customer management, regulatory compliance, data, quality, and commercial operations.
Shares of this leading life sciences software company have significantly underperformed the broader market over the past year. VEEV has plunged 14% over this period, while the broader S&P 500 Index ($SPX) has climbed nearly 19.3%. The stock has also underperformed in 2026, rising 8.7% year-to-date, compared to the index’s 12.4% gain.
